Clinical Trials Browser

Salivary Gland Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT06365788 2026-04-01

ABBICAR

Phase 2 Recruiting

53 enrolled

Breast

Bulbo-Spinal Atrophy, X-Linked, Triple Negative Breast Neoplasms

NCT04090528 2025-12-05

pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

Phase 2 Active not recruiting

60 enrolled 10 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT04926181 2025-05-15

Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer

Phase 2 Terminated

2 enrolled 12 charts

GenitourinaryThoracic

Prostatic Neoplasms, Carcinoma, Small Cell, Bulbo-Spinal Atrophy, X-Linked, Small Cell Lung Carcinoma

NCT03050866 2021-08-20

CABA-V7

Phase 2 Unknown

140 enrolled

Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT02348281 2018-01-23

Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients

Phase 2 Terminated

1 enrolled

Breast

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked, Triple Negative Breast Neoplasms

NCT02910050 2017-12-22

BETTER

Phase 2 Unknown

58 enrolled

Breast

Breast Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT00365599 2014-11-21

Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

Phase 2 Completed

43 enrolled 8 charts

Breast

Breast Neoplasms, Neoplasm Metastasis, Bulbo-Spinal Atrophy, X-Linked

NCT00918385 2014-10-29

ARS

Phase 2 Terminated

57 enrolled 8 charts

Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Clinical Trials

Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)

ABBICAR

pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer

Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer

CABA-V7

Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients

BETTER

Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer

ARS